Accredited Investors Inc. Sells 284 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Accredited Investors Inc. decreased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.6% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 7,535 shares of the healthcare conglomerate’s stock after selling 284 shares during the period. Accredited Investors Inc.’s holdings in UnitedHealth Group were worth $3,812,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of UNH. NewSquare Capital LLC purchased a new stake in UnitedHealth Group in the 4th quarter worth $25,000. Hurley Capital LLC purchased a new stake in UnitedHealth Group in the 4th quarter worth about $28,000. AlphaMark Advisors LLC bought a new position in UnitedHealth Group in the 4th quarter valued at $30,000. Aster Capital Management DIFC Ltd purchased a new position in UnitedHealth Group in the 4th quarter worth about $30,000. Finally, Promus Capital LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at approximately $32,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $580.16 on Thursday. The company has a fifty day moving average of $510.86 and a 200-day moving average of $541.73. The firm has a market capitalization of $530.68 billion, a P/E ratio of 37.43, a P/E/G ratio of 1.37 and a beta of 0.61. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same period in the previous year, the business earned $5.83 earnings per share. The firm’s quarterly revenue was up 6.8% compared to the same quarter last year. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.45%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s dividend payout ratio is currently 54.19%.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on UNH. Truist Financial dropped their price objective on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Barclays lowered their price target on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research report on Friday, January 17th. HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective for the company in a research note on Friday, January 10th. Wells Fargo & Company reduced their price target on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Finally, Mizuho lifted their price target on UnitedHealth Group from $600.00 to $650.00 and gave the stock an “outperform” rating in a research note on Wednesday. Twenty-one analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Buy” and an average price target of $630.35.

Insider Buying and Selling at UnitedHealth Group

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the firm’s stock in a transaction that occurred on Friday, January 17th. The shares were bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.